Seamus Mulligan, Director at Jazz Pharmaceuticals plc (JAZZ), sold 550,000 shares at $156.25 ($85.9M) on 2014-03-04, disclosed to the SEC on 2014-03-05.
Open-market sale of $85.9M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | BUY | 2018-11-19 | $14.2M | — | Filing → |
| JAZZ | SELL | 2016-08-26 | $6.0M | — | Filing → |
| JAZZ | SELL | 2016-05-26 | $8.2M | — | Filing → |